Ye, Xiaohua http://orcid.org/0000-0002-2300-4739
Shih, David J. H.
Ku, Zhiqiang
Hong, Junping
Barrett, Diane F.
Rupp, Richard E.
Zhang, Ningyan http://orcid.org/0000-0002-4348-2180
Fu, Tong-Ming
Zheng, W. Jim
An, Zhiqiang http://orcid.org/0000-0001-9309-2335
Funding for this research was provided by:
Welch Foundation (AU-0042-20030616)
Foundation for the National Institutes of Health (1UL1TR003167, AG066749-01)
Cancer Prevention and Research Institute of Texas (RP170668)
Article History
Received: 13 January 2023
Accepted: 26 February 2024
First Online: 1 April 2024
Competing interests
: The study was in part funded by Merck & Co., which was the sponsor of the V160-002 clinical trial. The Sponsor had no influence on data collection and interpretation of the data. The authors declare no competing interests.